ArticleProceedings of the National Academy of Sciences of the United States of America2018

Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.

Carlos A Orozco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.